These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 21044021)

  • 1. Novel anticoagulants: new evidence for emerging drugs and their potential application in major lower limb surgery.
    Nikolaou VS; Harwood PJ; Karadimas EJ; Tan HB; Giannoudis PV
    Curr Vasc Pharmacol; 2011 Jan; 9(1):54-60. PubMed ID: 21044021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetics and pharmacodynamics of the new oral anticoagulants dabigatran and rivaroxaban].
    Ordovás Baines JP; Climent Grana E; Jover Botella A; Valero García I
    Farm Hosp; 2009; 33(3):125-33. PubMed ID: 19712596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New anticoagulants for prevention and treatment of venous thromboembolism.
    Roberts LN; Arya R
    Curr Vasc Pharmacol; 2010 May; 8(3):373-82. PubMed ID: 19485902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The novel anticoagulants: entering a new era.
    Bounameaux H
    Swiss Med Wkly; 2009 Feb; 139(5-6):60-4. PubMed ID: 19204837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel oral factor Xa and thrombin inhibitors in the management of thromboembolism.
    Eriksson BI; Quinlan DJ; Eikelboom JW
    Annu Rev Med; 2011; 62():41-57. PubMed ID: 21226611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Two new anticoagulants available in 2010--Dabigatran Etexilate and Rivaroxaban: expected progresses--raised problems].
    Samama M; Conard J; Horellou MH; Le Flem L; Guinet C; Depasse F
    Ann Pharm Fr; 2010 Nov; 68(6):359-69. PubMed ID: 21073994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New anticoagulants for the prevention of thromboembolism.
    Lepic K; Crowther M
    Curr Pharm Des; 2010; 16(31):3472-4. PubMed ID: 20858184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New anticoagulants in the prevention and treatment of venous thromboembolism].
    Keltai M; Keltai K
    Orv Hetil; 2011 Jun; 152(25):983-92. PubMed ID: 21642050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dabigatran and rivaroxaban for prevention of venous thromboembolism--systematic review and adjusted indirect comparison.
    Loke YK; Kwok CS
    J Clin Pharm Ther; 2011 Feb; 36(1):111-24. PubMed ID: 21198726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventing postsurgical venous thromboembolism: pharmacological approaches.
    Tufano A; Coppola A; Cerbone AM; Ruosi C; Franchini M
    Semin Thromb Hemost; 2011 Apr; 37(3):252-66. PubMed ID: 21455859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel oral anticoagulants for thromboprophylaxis after orthopaedic surgery.
    Quinlan DJ; Eriksson BI
    Best Pract Res Clin Haematol; 2013 Jun; 26(2):171-82. PubMed ID: 23953905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulation with {blacktriangledown}dabigatran or{blacktriangledown}rivaroxaban.
    Drug Ther Bull; 2009 Oct; 47(10):116-20. PubMed ID: 19809086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term benefits of preventing venous thromboembolic events.
    Cohen AT
    Curr Med Res Opin; 2012 Jun; 28(6):877-89. PubMed ID: 22533680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New anticoagulants: focus on venous thromboembolism.
    Gómez-Outes A; Lecumberri R; Pozo C; Rocha E
    Curr Vasc Pharmacol; 2009 Jul; 7(3):309-29. PubMed ID: 19601856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New anticoagulants: dabigatran, rivaroxaban and apixaban].
    Vargas Ruiz AG; Ramírez López AN; Medina Viramontes ME
    Gac Med Mex; 2012; 148(3):257-64. PubMed ID: 22820359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New oral anticoagulant drugs: dabigatran, rivaroxaban and apixaban. Present and future].
    Dumont B; Faille D; Ajzenberg N
    Med Sci (Paris); 2011 May; 27(5):493-500. PubMed ID: 21609670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing practice of anticoagulation: will target-specific anticoagulants replace warfarin?
    Arepally GM; Ortel TL
    Annu Rev Med; 2015; 66():241-53. PubMed ID: 25587651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of dabigatran and rivaroxaban in primary prevention of venous thromboembolism in 106 patients, who have undergone major orthopedic surgery: an observational study.
    Samama MM; Guinet C; Le Flem L; Ninin E; Debue JM
    J Thromb Thrombolysis; 2013 Feb; 35(2):140-6. PubMed ID: 23335022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct thrombin and factor Xa inhibitors in children: a quest for new anticoagulants for children.
    Streif W; Ageno W
    Wien Med Wochenschr; 2011 Feb; 161(3-4):73-9. PubMed ID: 21404143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rivaroxaban for the prevention of venous thromboembolism following major orthopedic surgery: the RECORD trials.
    Ageno W
    Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):569-76. PubMed ID: 19505271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.